KM analyses also revealed a correlation between high COL5A1 expression levels and adverse outcome of patients with ACC (Figure 4(b), p = 0.029), BLCA (Figure 4(c), p = 0.024), GBM (Figure 4(d), p = 0.027), KIRC (Figure 4(e), p < 0.001), KIRP (Figure 4(f), p < 0.001), LGG (Figure 4(g), p = 0.002), MESO (Figure 4(h), p = 0.002), SKCM (Figure 4(i), p = 0.003), and UVM (Figure 4(b), p = 0.008). Here, COL5A1 is linked to adrenal cortex carcinoma.